Package 76420-497-60

{"route": ["ORAL"], "spl_id": "eaa81374-5d2c-60d1-e053-2a95a90af8ea", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310434"], "spl_set_id": ["9d544944-ea95-42e1-8c65-9e442437f0ee"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (76420-497-01)", "package_ndc": "76420-497-01", "marketing_start_date": "20221010"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (76420-497-05)", "package_ndc": "76420-497-05", "marketing_start_date": "20221010"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (76420-497-12)", "package_ndc": "76420-497-12", "marketing_start_date": "20221010"}, {"sample": false, "description": "240 TABLET in 1 BOTTLE (76420-497-24)", "package_ndc": "76420-497-24", "marketing_start_date": "20221010"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-497-30)", "package_ndc": "76420-497-30", "marketing_start_date": "20221010"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-497-60)", "package_ndc": "76420-497-60", "marketing_start_date": "20221010"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-497-90)", "package_ndc": "76420-497-90", "marketing_start_date": "20221010"}], "brand_name": "Gabapentin", "product_id": "76420-497_eaa81374-5d2c-60d1-e053-2a95a90af8ea", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "76420-497", "generic_name": "Gabapentin", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "800 mg/1"}], "application_number": "ANDA205101", "marketing_category": "ANDA", "marketing_start_date": "20160204", "listing_expiration_date": "20261231"}